Stewart Clark is an experienced quality and compliance professional with a strong background in the biotechnology and pharmaceutical industries. Currently serving as Quality Manager at Onya Therapeutics since March 2023, Stewart is responsible for managing quality, health, and safety operations. As Chief Scientific Officer at Fulhold Pharma Ltd since August 2021, Stewart oversees the strategic development of CHD-FA, ensuring compliance in market access. A longstanding Quality and Compliance Specialist at Biophys Ltd since January 2009, key projects include obtaining ISO 9001 certification and advising the National Oceanographic Centre on microbial ecology. Previous roles include Quality Manager at Neem Biotech Limited, where Stewart managed quality processes, and Quality Specialist at Fresenius Kabi, focusing on large volume parenteral medicines. Stewart holds a PhD in Microbiology from Montana State University-Bozeman and an MSc in Biotechnology from Rhodes University.
This person is not in any teams
This person is not in any offices